CARD11 signaling in regulatory T cell development and function.

Area of Science:

• Immunology
• Cell Signaling
• Molecular Biology

Background:

• Regulatory T cells (Tregs) are vital CD4 T cells that maintain immune homeostasis by preventing autoimmunity and chronic inflammation.
• CARD11 acts as a key signaling hub, connecting antigen receptor signals to downstream pathways like NF-κB, which is critical for Treg development and function.
• While CARD11 signaling defects often lead to Treg dysfunction, the resulting autoimmune or inflammatory phenotypes vary across different mouse models.

Purpose of the Study:

• To review the current evidence on the role of CARD11 signaling in the development and function of regulatory T cells.
• To highlight the implications of CARD11 signaling in Treg-mediated immune responses, including autoimmunity, inflammation, and anti-tumor immunity.
• To identify key unanswered questions and future research directions in the field of CARD11 and Treg biology.

Main Methods:

• Literature review of studies investigating CARD11 signaling in T cells.
• Analysis of data from mouse models with CARD11 deficiencies or related pathway alterations.
• Synthesis of findings related to Treg development, function, and disease association.

Main Results:

• CARD11 is indispensable for the development and function of thymic regulatory T cells.
• Dysregulation of CARD11 signaling in Tregs is linked to immune defects, with varying degrees of autoimmunity and inflammation observed in different models.
• Targeting CARD11 signaling in Tregs within the tumor microenvironment presents a potential strategy to enhance anti-tumor immunity.

Conclusions:

• CARD11 signaling plays a fundamental role in regulatory T cell biology.
• Further research is needed to fully elucidate the complex mechanisms of CARD11 in Treg function and its therapeutic implications.
• Understanding CARD11 signaling offers opportunities for novel therapeutic interventions in autoimmune diseases and cancer immunotherapy.